Q3 2024 · 13F-HR
Pale Fire Capital SEholdings as filed
Filed 2024-11-12 · accession 0000921895-24-002578
$637.7M
Reported value
54
Positions
2024-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 00206R102 | T | AT&T INC | $211.3M | 33.1% | 9,603,558 | Common | SHARED |
| G27907107 | DOLE | DOLE PLC | $106.7M | 16.7% | 6,547,483 | Common | SHARED |
| 399473206 | GRPN | GROUPON INC | $99.6M | 15.6% | 10,181,070 | Common | SHARED |
| 11777Q209 | BTG | B2GOLD CORP | $52.9M | 8.30% | 17,186,079 | Common | SHARED |
| Y41053102 | INSW | INTERNATIONAL SEAWAYS INC | $38.9M | 6.10% | 754,415 | Common | SHARED |
| 87918A105 | TDOC | TELADOC HEALTH INC | $18.8M | 2.95% | 2,047,323 | Common | SHARED |
| 152006102 | CGAU | CENTERRA GOLD INC | $15.9M | 2.49% | 2,216,410 | Common | SHARED |
| 00183L102 | ANGI1EUR | ANGI INC | $13.9M | 2.18% | 5,395,100 | Common | SHARED |
| G9108L173 | TEN | TSAKOS ENERGY NAVIGATION LTD | $12.7M | 1.99% | 504,398 | Common | SHARED |
| 44955L106 | IAUX | I-80 GOLD CORP | $11.5M | 1.80% | 9,889,569 | Common | SHARED |
| Y62267409 | NMM | NAVIOS MARITIME PARTNERS L P | $10.7M | 1.67% | 170,226 | Common | SHARED |
| 16934Q802 | CIM | CHIMERA INVT CORP | $5.4M | 0.84% | 339,473 | Common | SHARED |
| 74006W207 | PRAX | PRAXIS PRECISION MEDICINES I | $3.9M | 0.61% | 67,284 | Common | SHARED |
| 67576A100 | OCUL | OCULAR THERAPEUTIX INC | $3.8M | 0.60% | 438,200 | Common | SHARED |
| 825690100 | SSTK | SHUTTERSTOCK INC | $3.4M | 0.53% | 95,810 | Common | SHARED |
| Y7542C130 | STNG | SCORPIO TANKERS INC | $3.2M | 0.51% | 45,310 | Common | SHARED |
| 684060106 | ORANY | ORANGE | $2.9M | 0.45% | 251,125 | Common | SHARED |
| 780259305 | SHEL | SHELL PLC | $2.7M | 0.42% | 40,925 | Common | SHARED |
| 00773U207 | AVU0 | ADVERUM BIOTECHNOLOGIES INC | $2.2M | 0.34% | 308,371 | Common | SHARED |
| 25525P107 | DHC | DIVERSIFIED HEALTHCARE TR | $1.9M | 0.29% | 442,298 | Common | SHARED |
| N90064101 | QURE | UNIQURE NV | $1.7M | 0.26% | 336,468 | Common | SHARED |
| 603170101 | MLYS | MINERALYS THERAPEUTICS INC | $1.7M | 0.26% | 136,897 | Common | SHARED |
| 142038108 | CRBU | CARIBOU BIOSCIENCES INC | $1.4M | 0.23% | 734,904 | Common | SHARED |
| 649604840 | ADAM | NEW YORK MTG TR INC | $1.3M | 0.21% | 207,971 | Common | SHARED |
| G27358103 | DESP1EUR | DESPEGAR COM CORP | $1.2M | 0.19% | 99,938 | Common | SHARED |
| 98420X103 | ASNSUSD | X4 PHARMACEUTICALS INC | $1.1M | 0.17% | 1,602,792 | Common | SHARED |
| 75382E109 | — | RAPT THERAPEUTICS INC | $1.0M | 0.16% | 510,724 | Common | SHARED |
| 001228501 | MITT | AG MTG INVT TR INC | $1.0M | 0.16% | 133,271 | Common | SHARED |
| 45790W108 | — | INOZYME PHARMA INC | $986,049 | 0.15% | 188,537 | Common | SHARED |
| G7500M104 | RNW | RENEW ENERGY GLOBAL PLC | $372,928 | 0.06% | 59,289 | Common | SHARED |
| 462260100 | IOVA | IOVANCE BIOTHERAPEUTICS INC | $350,951 | 0.06% | 37,375 | Common | SHARED |
| 254604101 | IRON | DISC MEDICINE INC | $324,766 | 0.05% | 6,609 | Common | SHARED |
| N44445109 | IMTX | IMMATICS N.V | $279,111 | 0.04% | 24,462 | Common | SHARED |
| G1110E107 | BHVN | BIOHAVEN LTD | $274,635 | 0.04% | 5,496 | Common | SHARED |
| 15102K100 | CELC | CELCUITY INC | $260,299 | 0.04% | 17,458 | Common | SHARED |
| 125525584 | — | CREATIVE MEDIA & CMNTY TR | $239,055 | 0.04% | 486,378 | Common | SHARED |
| 16934W106 | CMRXEUR | CHIMERIX INC | $237,116 | 0.04% | 254,963 | Common | SHARED |
| 09203E105 | BDTX | BLACK DIAMOND THERAPEUTICS I | $230,485 | 0.04% | 52,985 | Common | SHARED |
| 92539P101 | — | VERVE THERAPEUTICS INC | $220,704 | 0.03% | 45,600 | Common | SHARED |
| 89854M101 | TCRX | TSCAN THERAPEUTICS INC | $217,741 | 0.03% | 43,723 | Common | SHARED |
| 517125100 | LRMR | LARIMAR THERAPEUTICS INC | $211,624 | 0.03% | 32,309 | Common | SHARED |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $205,139 | 0.03% | 7,686 | Common | SHARED |
| 004468500 | ACHV | ACHIEVE LIFE SCIENCES INC | $156,984 | 0.02% | 33,119 | Common | SHARED |
| 03843E104 | AQST | AQUESTIVE THERAPEUTICS INC | $119,520 | 0.02% | 24,000 | Common | SHARED |
| 76200L309 | RZLT | REZOLUTE INC | $117,802 | 0.02% | 24,289 | Common | SHARED |
| 87184Q206 | SYRS | SYROS PHARMACEUTICALS INC | $105,804 | 0.02% | 49,211 | Common | SHARED |
| 20454B104 | CMPX | COMPASS THERAPEUTICS INC | $56,133 | 0.01% | 30,507 | Common | SHARED |
| 15117F807 | CLRBUSD | CELLECTAR BIOSCIENCES INC | $53,564 | 0.01% | 25,030 | Common | SHARED |
| 68828E809 | ODV | OSISKO DEVELOPMENT CORP | $51,740 | 0.01% | 24,291 | Common | SHARED |
| 11161T207 | BWEN | BROADWIND INC | $49,999 | 0.01% | 22,026 | Common | SHARED |
| 64782A107 | NEWP | NEW PAC METALS CORP | $49,960 | 0.01% | 33,530 | Common | SHARED |
| 723836300 | PPSI | PIONEER PWR SOLUTIONS INC | $49,245 | 0.01% | 10,500 | Common | SHARED |
| N0731H103 | ATAI | ATAI LIFE SCIENCES NV | $43,365 | 0.01% | 37,384 | Common | SHARED |
| 92243A200 | VXRT | VAXART INC | $43,323 | 0.01% | 51,028 | Common | SHARED |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.